Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410691 | SCV000486511 | likely pathogenic | Bloom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000410691 | SCV000916680 | pathogenic | Bloom syndrome | 2017-12-29 | criteria provided, single submitter | clinical testing | Variant summary: The BLM c.1284G>A (p.Trp428X) variant results in a premature termination codon, predicted to cause a truncated or absent BLM protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.1544delA (p.Asn515fsX16), c.1642C>T (p.Gln548X), and c.1933C>T (p.Gln645X)). This variant is absent in 245796 control chromosomes (gnomAD). A publication, German_2007, cites the variant in two compound heterozygote Bloom Syndrome patients. In addition, a clinical diagnostic laboratory classified this variant as likely pathogenic. Taken together, this variant is classified as pathogenic. |
Labcorp Genetics |
RCV000410691 | SCV000942374 | pathogenic | Bloom syndrome | 2023-02-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp428*) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Bloom syndrome (PMID: 17407155, 29098565). ClinVar contains an entry for this variant (Variation ID: 371048). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV000410691 | SCV001440408 | pathogenic | Bloom syndrome | 2019-01-01 | criteria provided, single submitter | clinical testing | This variant was identified as compound heterozygous. |
Natera, |
RCV000410691 | SCV002090025 | pathogenic | Bloom syndrome | 2017-03-16 | no assertion criteria provided | clinical testing |